Abcc11 Gene
The ABCC11 gene encodes an ATP binding cassette (ABC) transporter protein that moves substrates across cellular membranes, with a well known polymorphism (rs17822931) determining human earwax type and influencing metabolic processes. This guide is for researchers, clinicians, and bioinformatics analysts who need a practical, source bounded understanding of ABCC11 function, variant analysis, and interpretation limits.
ABCC11 belongs to the C subfamily of ABC transporters and is expressed in multiple tissues including the liver, breast, and ear canal epithelium source: NCBI Bookshelf. The protein transports lipophilic molecules such as conjugated bile acids, steroid hormones, and various xenobiotics. A single nucleotide polymorphism, rs17822931 (538G>A, G180R), leads to a nonfunctional transporter and is the primary determinant of dry earwax in East Asian populations. Beyond earwax, ABCC11 has been implicated in drug resistance in cancer cells, chemosensitivity in non small cell lung cancer, and susceptibility to otological disorders.
At a Glance
| Feature | Description |
|---|---|
| Gene name | ABCC11 (ATP Binding Cassette Subfamily C Member 11) |
| Chromosomal location | 16q12.1 |
| Protein function | Efflux transporter of lipophilic organic anions |
| Key variant | rs17822931 (538G>A, G180R) |
| Major phenotypic association | Earwax type (wet vs dry) |
| Clinical relevance | Chemotherapy response, cholesteatoma risk, metabolic regulation |
| Populations with highest dry earwax frequency | East Asian (Japanese, Chinese, Korean) |
| Expression pattern | Liver, breast, adrenal gland, ear canal, lung |
Core Concepts and Functions
ABCC11 functions as an ATP dependent export pump localized to the apical membrane of polarized cells. The transporter effluxes a range of endogenous and exogenous compounds including steroid hormone conjugates, cyclic nucleotides, and certain chemotherapeutic agents. The loss of function variant G180R eliminates transporter activity, which alters the composition of cerumen and may affect local drug concentrations in tissues expressing the protein.
The rs17822931 variant has been under positive selection in East Asian populations, likely due to its association with reduced body odor and decreased axillary sweat secretion. A recent genomic study using coalescent methods identified ABCC11 as a target of recent selection in East Asian populations, providing population level evidence for its adaptive significance source: Fast pairwise coalescence enables gene resolution scans for recent selection in diverse human populations. In the Zhuang people of southern China, admixture mapping and selection scans further supported the role of ABCC11 in adaptive evolution related to physiological traits source: Genomic insights into the admixture history and adaptive evolution of the Zhuang people.
Clinically, the G180R variant has been investigated in otology. A hospital based case control study at Heidelberg University Hospital found that older adults carrying the rs17822931 variant had altered risk profiles for middle ear cholesteatoma, suggesting that ABCC11 function influences local homeostasis in the ear canal and middle ear source: Association of the rs17822931 (538G>A, G180R) in the ABCC11 gene with risk of middle ear cholesteatoma in older adults. In oncology, ABCC11 polymorphisms have been linked to differential responses to EGFR tyrosine kinase inhibitors in EGFR mutant non small cell lung cancer. A study examining ABCB1 and ABCC10 polymorphisms also highlighted the broader ABC transporter family's role in treatment sensitivity, highlighting the importance of transporter pharmacogenetics source: ABCB1 and ABCC10 polymorphisms predict sensitivity to first and third generation EGFR TKIs in EGFR mutant NSCLC.
At the cellular level, ABCC11 expression is regulated by metabolic status. Transcriptomic and proteomic profiling of lipid loaded HepaRG cells revealed altered regulation of ABC transporters including ABCC11 in steatosis, linking the gene to lipid and xenobiotic metabolism source: Transcriptomic and Proteomics Analysis of a Lipid Loaded HepaRG Model for Steatosis. Additionally, analysis of exome data from 5000 Chinese individuals estimated the genetic load contributed by loss of function variants in ABC transporters, including ABCC11, and their potential impact on health source: Estimating genetic load from 5000 Chinese exomes.
Decision Points for ABCC11 Analysis
What research question are you asking?
ABCC11 analysis can address several distinct questions. If you are investigating earwax type as a phenotype, you will focus on genotyping rs17822931. If your interest is drug resistance in cancer, you may need to measure ABCC11 expression levels and assess multiple polymorphisms. For population genetics, you should examine haplotype structure and selection signals.
Choose your sample type and source.
For variant genotyping, DNA from blood, saliva, or tissue is appropriate. For expression analysis, you need RNA from relevant tissues such as liver, breast, or ear canal epithelium. Publicly available data from sources like the NCBI Sequence Read Archive can be used for in silico analysis source: NCBI Sequence Read Archive.
Select your analytical approach.
For targeted genotyping, use PCR based methods, Sanger sequencing, or microarray. For discovery based work, whole exome or whole genome sequencing is better. For expression quantification, RNA sequencing or qRT PCR are suitable. For population genetics, use coalescent based tools to detect selection.
Define your control population.
The allele frequency of rs17822931 varies dramatically across populations. East Asian populations have a high frequency of the A allele (dry earwax), while African and European populations have a very low frequency. Always match your control group by ancestry to avoid spurious associations.
Practical Workflow for ABCC11 Analysis
Step 1: Define the hypothesis and select the variant.
First, identify whether you need to assess the common functional variant rs17822931, screen for rare variants in ABCC11, or measure expression levels. For most applications, the G180R variant is the priority target. Use population frequency databases to understand your expected variant prevalence.
Step 2: Obtain or generate sequence data.
Collect DNA samples and perform genotyping for rs17822931 using a validated assay such as TaqMan or KASP. For broader screening, use whole exome or genome sequencing with at least 30x coverage. For expression analysis, extract RNA from the relevant tissue and sequence with at least 20 million reads per sample. Use the Sequence Read Archive to download publicly available datasets if needed.
Step 3: Process and call variants.
Use standard bioinformatics pipelines. For variant calling from sequencing data, follow best practices from the Genome Analysis Toolkit (GATK). For RNA seq analysis, use an aligner such as STAR followed by featureCounts. The Galaxy Training Network provides reproducible workflows for both DNA seq and RNA seq analysis that can be adapted for ABCC11 studies source: Galaxy Training Network.
Step 4: Perform statistical association.
For case control studies, use logistic regression adjusting for age, sex, and population structure. For continuous traits, use linear regression. For expression analysis, compare normalized counts between groups using DESeq2 or edgeR which are available through Bioconductor source: Bioconductor. Include the most relevant covariates based on your study design.
Step 5: Validate findings.
Replicate the association in an independent cohort. For functional validation, consider in vitro transport assays using cell lines expressing wild type or variant ABCC11. For population selection studies, use multiple independently ascertained datasets to confirm signals.
Step 6: Interpret in context.
Place your findings in the context of the known population genetics, clinical associations, and functional biology of ABCC11. Consider the effect size, confidence intervals, and whether the association is plausible given the transporter's known substrates and tissue expression.
Quality Checks
Verify that your genotyping assay discriminates correctly between the G and A alleles at rs17822931. Include known positive controls (samples with known genotypes) and no template controls. For sequencing data, assess read depth at the ABCC11 locus. A depth of at least 20 reads is required for confident heterozygous calls. Check for strand bias or mapping issues in repetitive regions of the gene. For expression data, examine principal component plots to rule out batch effects that could confound the analysis. Always compute Hardy Weinberg equilibrium in control populations to detect genotyping errors.
Common Mistakes
One frequent error is assuming that rs17822931 is the only functionally important ABCC11 variant. While it is the most impactful single variant, rarer coding and regulatory variants can also alter transporter function and may contribute to complex traits. A second mistake is failing to account for population stratification in association studies. Because the variant frequency differs dramatically between ancestries, even modest population mismatching can produce false positive or false negative results. A third error is interpreting ABCC11 expression changes in bulk tissues without considering cell type specificity. The transporter is expressed only in certain cell types within a tissue, and bulk measurements may dilute meaningful signals. A fourth mistake is assuming that the G180R variant directly causes all observed phenotypic associations without considering linkage disequilibrium with other nearby functional variants.
Limits of Interpretation
The most robust association for ABCC11 is earwax type, which has near complete penetrance in individuals homozygous for the A allele. However, other reported associations often have modest effect sizes and may not replicate across populations. The selection signals detected in East Asian populations are statistically robust, but the exact selective pressure (e.g., reduced body odor or altered sweat composition) remains speculative. In pharmacogenomic studies, ABCC11 effects on drug response are often small compared to other factors such as drug metabolism genes or tumor mutations. The transcriptomic changes observed in steatosis models may reflect secondary consequences of lipid accumulation rather than a primary role for ABCC11. Finally, the genetic load estimates from exome data depend on assumptions about variant penetrance and may not translate directly to clinical risk.
Frequently Asked Questions
Is ABCC11 the only gene that determines earwax type?
No, but it is the primary determinant. The rs17822931 variant in ABCC11 explains more than 90% of the variation in earwax type in East Asian populations. Other genetic and environmental factors may have minor influences, but ABCC11 is the major gene.
Can ABCC11 testing be used to predict cancer drug response?
Currently, ABCC11 genotyping is not part of standard clinical care for any cancer type. Some studies suggest associations with response to chemotherapies like fluoropyrimidines and EGFR inhibitors, but the evidence is not strong enough for routine use. Testing remains a research tool.
Does everyone with dry earwax have the ABCC11 G180R variant?
The majority of individuals with dry earwax are homozygous for the A allele at rs17822931. However, a small number of people with dry earwax carry other rare loss of function variants in ABCC11 or have dry earwax due to other causes such as age related changes or cerumen impaction treatments.
How can I obtain ABCC11 expression data for my research?
You can download publicly available RNA sequencing data from the NCBI Sequence Read Archive, the Genotype Tissue Expression (GTEx) project, or the Cancer Genome Atlas (TCGA). Use Bioconductor packages like recount3 or ExpressionAtlas to access processed data ready for analysis.
References and Further Reading
- NCBI Bookshelf: ABC Transporters Overview An authoritative technical reference on ABC transporter family structure and function.
- EMBL EBI Training: Human genetic variation analysis Practical training materials for working with genetic variant data including population frequency information.
- Galaxy Training Network: Variant calling workflow Step by step training for germline variant detection from whole exome and genome sequencing.
- Bioconductor: DESeq2 for differential expression Software and documentation for analyzing count based RNA seq data with statistical rigor.
- NCBI Sequence Read Archive: Public sequencing data repository Primary public repository for raw sequencing data from diverse studies including those examining ABCC11.
- Fast pairwise coalescent selection scan in diverse human populations Provides population genetic evidence for recent selection on ABCC11.
- Genomic insights into Zhuang people adaptive evolution Admixture and selection analysis confirming ABCC11 adaptive significance in East Asian populations.
- ABCC11 rs17822931 and middle ear cholesteatoma risk Clinical study linking the earwax variant to otological disease susceptibility.
- ABC transporter polymorphisms and EGFR TKI sensitivity Pharmacogenetic study contextualizing ABCC11 within broader transporter mediated drug responses.
- ABCC11 regulation in steatosis HepaRG model Transcriptomic and proteomic data showing ABCC11 involvement in lipid and xenobiotic metabolism.